KP requests the cooperation of Providers in monitoring their own practice for reporting of communicable diseases including COVID-19 during the pandemic, aimed at prevention of hospital associated infection (HAI) including, but not limited to, multi-drug resistant organisms such as MRSA, VRE, and C.difficile (C.diff), postoperative surgical site infections, central line associated bloodstream infections, and导管相关的尿路感染。应跟踪目标HAI,确定速率并将其与CDC基准进行比较。确定潜在感染时,请通知局部感染预防主义。确认该设施中的HAI案件已按照要求的公开报告所要求的,并将其输入疾病与控制中心(CDC)数据库(CDC)数据库(NHSN)。当附属从业人员或提供者确定趋势时,应与地方感染控制委员会(ICC)共享这一趋势,并应采取协作方法以改善与预防感染和控制有关的实践。所有HAI摘要报告和分析都应持续提交给KP ICC和质量管理(QM)部门。本审查的结果应与关联从业者或提供者共享。IP和QM部门将要求采取某些行动和干预措施,以最大程度地提高患者安全。
主要关键词